BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26482635)

  • 1. [Medico-economic impact of an innovative management of CHF by HF unit].
    Baudouin C; Groshens S; Gueneau P; Rousseau M; Saura M; Hryschyschyn N; Hillani A; Dagorn J; Pitthan E; Jourdain P
    Ann Cardiol Angeiol (Paris); 2015 Nov; 64(5):318-24. PubMed ID: 26482635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a multidimensional home nurse led heart failure disease management program--a French nationwide time-series comparison.
    Agrinier N; Altieri C; Alla F; Jay N; Dobre D; Thilly N; Zannad F
    Int J Cardiol; 2013 Oct; 168(4):3652-8. PubMed ID: 23809709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial.
    Stewart S; Carrington MJ; Marwick TH; Davidson PM; Macdonald P; Horowitz JD; Krum H; Newton PJ; Reid C; Chan YK; Scuffham PA
    J Am Coll Cardiol; 2012 Oct; 60(14):1239-48. PubMed ID: 23017533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Heart Failure Observed in Emergency Departments, Ambulatory Clinics, and Hospitals.
    Camplain R; Kucharska-Newton A; Keyserling TC; Layton JB; Loehr L; Heiss G
    Am J Cardiol; 2018 Jun; 121(11):1328-1335. PubMed ID: 29576231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure.
    Correia J; Silva FF; Roque C; Vieira H; Providéncia LA
    Rev Port Cardiol; 2007 Apr; 26(4):335-43. PubMed ID: 17695729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF).
    Dokainish H; Teo K; Zhu J; Roy A; Al-Habib K; ElSayed A; Palileo L; Jaramillo PL; Karaye K; Yusoff K; Orlandini A; Sliwa K; Mondo C; Lanas F; Dorairaj P; Huffman M; Badr A; Elmaghawry M; Damasceno A; Belley-Cote E; Harkness K; Grinvalds A; McKelvie R; Yusuf S
    Am Heart J; 2015 Oct; 170(4):627-634.e1. PubMed ID: 26386785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.
    Czech M; Opolski G; Zdrojewski T; Dubiel JS; Wizner B; Bolisęga D; Fedyk-Łukasik M; Grodzicki T
    Kardiol Pol; 2013; 71(3):224-32. PubMed ID: 23575775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.
    Wijeysundera HC; Machado M; Wang X; Van Der Velde G; Sikich N; Witteman W; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Value Health; 2010 Dec; 13(8):915-21. PubMed ID: 21091970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Heart Failure: Alternatives to Hospitalization.
    Zsilinszka R; Mentz RJ; DeVore AD; Eapen ZJ; Pang PS; Hernandez AF
    JACC Heart Fail; 2017 May; 5(5):329-336. PubMed ID: 28285117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of heart failure: investigating outpatient and inpatient costs in Abeokuta, Southwest Nigeria.
    Ogah OS; Stewart S; Onwujekwe OE; Falase AO; Adebayo SO; Olunuga T; Sliwa K
    PLoS One; 2014; 9(11):e113032. PubMed ID: 25415310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
    Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
    Arch Cardiovasc Dis; 2013 Nov; 106(11):570-85. PubMed ID: 24140417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.
    Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R
    Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
    Vaishnav J; Hubbard A; Chasler JE; Lepley D; Cuomo K; Riley S; Menzel K; Fajardo J; Sharma K; Judge DP; Russell SD; Gilotra NA
    Am Heart J; 2021 Mar; 233():122-131. PubMed ID: 33352187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of a nurse-based heart failure management program on hospitalization rate, functional status, quality of life, and medical costs].
    Chinaglia A; Gaschino G; Asteggiano R; Titta G; Gullstrand R; Bobbio M; Trinchero R
    Ital Heart J Suppl; 2002 May; 3(5):532-8. PubMed ID: 12064192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of supervised exercise therapy in heart failure patients.
    Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource use in the last 6 months of life among patients with heart failure in Canada.
    Kaul P; McAlister FA; Ezekowitz JA; Bakal JA; Curtis LH; Quan H; Knudtson ML; Armstrong PW
    Arch Intern Med; 2011 Feb; 171(3):211-7. PubMed ID: 20937918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.